Industry Intelligence for Technology, Industrial, and Emerging Sectors
Independent market intelligence and strategic analysis helping organizations understand technology adoption, industry trends, and competitive dynamics.
Trusted by Global Industry Leaders
Strategic Intelligence
In-depth market intelligence across global technology, industrial, and emerging sectors supporting strategic decision making.
Automation & Robotics
AI-enabled robotics, predictive maintenance and intelligent automation reshaping manufacturing operations.
Explore Research →Semiconductors
Advanced packaging, AI workloads and global fabrication investments reshaping semiconductor markets.
Explore Research →Energy & Power
Renewable integration, hydrogen investment and grid modernization accelerating energy transformation.
Explore Research →Agriculture Technology
Precision farming, automation and agrivoltaics expanding across global agricultural systems.
Explore Research →Healthcare Technologies
AI diagnostics, biotechnology and digital health platforms redefining healthcare delivery.
Explore Research →Advanced Materials
Next-generation materials enabling innovation across electronics, batteries and industrial manufacturing.
Explore Research →Featured Market Research
Predictive Maintenance Robotics Market
AI-enabled inspection and maintenance robots are expanding across industrial facilities as manufacturers prioritize predictive maintenance and operational uptime.
5G NTN Backhaul Market
Satellite backhaul is emerging as a key component of 5G Non-Terrestrial Networks, enabling coverage expansion for rural connectivity, maritime communications, and aviation networks.
Artificial Intelligence (AI) In Oil And Gas Market
AI-driven analytics and automation are enabling oil and gas companies to optimize drilling operations, enhance reservoir management, and improve predictive maintenance across upstream and downstream assets.
Thought Leadership
Insights and analysis from our research team on emerging technologies, market developments, and competitive dynamics.
Press Releases
Official announcements and market research updates from Knowledge Sourcing Intelligence (KSI).
Pharmacogenomics Platforms Market is expected to reach USD 10.1 billion by 2031
The pharmacogenomics platforms market is expanding at a rapid pace. Personalized medicine and genomic testing are the factors pushing the sales of pharmacogenomics products. Companion diagnostics for the treatment of various diseases also lead to demand for pharmacogenomics platforms. Drug-response analysis is becoming easier and faster due to innovative NGS, PCR, and bioinformatics platforms. The use of AI-based tools for precision medicine is one of the key market drivers. Predictive analytics, biomarker discovery, and genomic interpretation are the major areas that have been impacted by AI technologies.
Digital Biomarkers for Clinical Diagnostics Market is expected to reach USD 22.9 billion by 2031
The global digital biomarkers in clinical diagnostics market is experiencing robust growth because of the growing use of digital health technologies and the necessity to monitor patients constantly, in real-time. Digital biomarkers exploit data gathered by wearable devices, smartphones, and other connected health platforms to provide objective, quantifiable measures of the physiological and behavioral states. These biomarkers allow early diagnosis, disease surveillance and personalized treatment options in place of a large spectrum of clinical disorders.
Companion Diagnostics For Targeted Therapies Market is expected to reach USD 15.1 billion by 2031
In 2025, there will be a rapid expansion of the companion diagnostics-targeted therapies ecosystem due to a combination of growing precision medicine use and new and improved regulatory compliance with organisations such as the U.S. Food and Drug Administration, which will be the driving force behind this development. Companion diagnostics (CDx) are in vitro diagnostic (IVD) devices designed to help physicians use targeted drugs by identifying the required biomarkers in patients before they begin treatment.The U.S. FDA approved 46 new drugs in 2025, primarily drugs associated with drug treatment strategies based on biomarkers, and numerous new companion diagnostic devices to accompany these drugs to diagnose patients with malignant neoplasms of the lung, breast, and ovary to ensure appropriate patient selection for such therapies as immunotherapy and kinase inhibitors.Regulatory strategies aimed at reclassifying specific tests for companion diagnostics are being discussed to expedite test approvals and thus provide greater access to testing for patients, which will support the continuing growth of the convergence of the diagnostic and therapeutic markets.
The KSI Research Advantage
Knowledge Sourcing Intelligence delivers independent market intelligence across technology, industrial, and emerging sectors. Our research combines primary interviews, proprietary datasets, and structured forecasting models to help organizations make informed strategic decisions.
Research Coverage
8,000+ market research reports covering global industries including semiconductors, energy, automation, healthcare, agriculture, and advanced materials.
Industry Expertise
Research led by analysts specializing in sector-specific intelligence, technology adoption trends, competitive benchmarking, and investment analysis.
Strategic Forecasting
Multi-year market forecasts supported by quantitative modeling, regulatory analysis, and global industry tracking across more than 60 countries.
Need Custom Market Intelligence?
Speak with our analysts about custom research, market sizing, or competitive analysis.